Latest News and Press Releases
Want to stay updated on the latest news?
-
Kennzahlen In Millionen Euro 4Q 04 (pro formaIFRS 2004) 3Q 05 (IFRS 2005) 4Q 05 (IFRS 2005) 12M04 (pro forma IFRS 2004) 12M05 (IFRS 2005) Konsolidierter...
-
Lucentis the first investigational therapy to improve vision in patients with wet AMD EU filing follows US submission by Genentech Two Phase III studies show Lucentis...
-
Basel, 2. März, 2006 "Mit diesen bemerkenswerten Ergebnissen machen Basilea und unser Partner Cilag AG International einen sehr bedeutenden und positiven Schritt nach vorne. Ceftobiprol hat...
-
Basel, Switzerland, March 2, 2006 "These exciting results are a very important and a positive step forward for Basilea and our partner, Cilag AG International. Ceftobiprole has performed...
-
Basel, 2. März, 2006 "Mit diesen bemerkenswerten Ergebnissen machen Basilea und unser Partner Cilag AG International einen sehr bedeutenden und positiven Schritt nach vorne. Ceftobiprol...
-
De voorlegging van CIMZIA(TM) vertegenwoordigt een belangrijke stap in het goedkeuringsproces voor de eerste subcutane behandeling van de ziekte van Crohn. BRUSSEL (België) en ATLANTA, GA...
-
Cette soumission du dossier CIMZIA(TM) constitue une étape majeure dans l'approbation du premier traitement sous-cutané de la maladie de Crohn BRUXELLES (Belgique) et ATLANTA, Géorgie...
-
CIMZIATM submission represents a major step towards the approval of the first ever subcutaneous treatment for Crohn's disease BRUSSELS (Belgium) and ATLANTA, Georgia (USA), March 2,...
-
HOUSTON, March 2, 2006 (PRIMEZONE) -- SYSCO Corporation (NYSE: SYY) today announced plans to construct a broadline foodservice "fold-out" facility in eastern Tennessee. The site selected by the...
-
NEW YORK, March 1, 2006 (PRIMEZONE) -- JetBlue Airways (Nasdaq:JBLU) will waive its change fees and any fare differences to allow customers with reservations for travel on Thursday, March 2, to or...